EnXray Hires Commercial Director
LIVERPOOL, England–(BUSINESS WIRE)–EnXray Ltd, developers of innovative sterilization equipment, today
announced that Robert Barlow has joined the senior management of the
company as Commercial Director to support the pre-commercialization
activities and launch of its ground breaking Low Energy X-ray (LEXR)
sterilization equipment. The LEXR equipment enables on-site and
on-demand sterilization of medical devices and consumables at the point
of manufacture.
Robert joins EnXray following a successful 25-year career in commercial
sales & marketing in the healthcare and medical device industry most
recently at Covidien (now Medtronic) as well as with venture capital
backed start-ups (e.g. Lynton Lasers and Microsulis Medical). Robert
will be responsible for implementing EnXray’s commercialisation
strategy, driving sales and developing customer relationships.
Ed Cappabianca, co-founder and CEO of EnXray, said: “Robert’s
understanding of the global medical device industry and success building
and leading teams capable of introducing new technology will be of great
benefit to EnXray.”
Robert Barlow, Commercial Director, commented: “I am delighted to
be joining EnXray at a time when markets are being disrupted by new and
innovative services and solutions. Our LEXR System is one of those
pioneering technologies that will challenge the status quo and create
significant competitive advantages for our customers. We have an
incredibly exciting journey ahead of us.”
EnXray will be at the XIVth
Anglo Nordic Life Science Conference on Wednesday, 31st
May 2017. Ed Cappabianca, CEO, will be presenting an overview on the
Company’s technology and he and Robert Barlow will be available for
meetings.
Visit www.enxray.com
for more information.
Notes to editors
About EnXray Limited
EnXray Limited (EnXray) is a development-stage technology company
founded in 2012, focused on commercializing its proprietary Low Energy
X-rays (LEXR) technology for use in sterilization. EnXray’s first target
market is the medical device manufacturing industry, where our
technology will enable companies to manage and control the sterilization
of their products (the final critical step of their production process)
on-site & on-demand, providing significant benefits to its customers.
Today, the global medical device manufacturing industry relies upon
large scale remote sterilization facilities, which creates significant
logistics issues for manufacturers, as well as their end customers, such
as hospitals and the NHS.
LEXR, or “soft x-rays” are a form of ionizing radiation in the range of
5 – 20 keV, which have some compelling characteristics, including a
short transmission range through air, combined with a high absorption
coefficient, which makes it a very efficient method for delivering high
dosages of radiation in a relatively short period of time, without the
need for extensive shielding. This is different from gamma-irradiation,
where products have to be paletted in order to get reasonable
sterilization efficacy, LEXR is designed for end-of-line processing and
sterilization of individual products.
For further information please go to: http://www.enxray.com/news.html
Contacts
EnXray Limited
Edward Cappabianca, +44 77 11 98 43 45
Chief
Executive Officer
[email protected]